Ketamine sits in two places at once, and that is the confusing part. It is a medicine used under supervision. It is also a drug people use outside that setting, and the difference matters clinically. Federal research summaries say that using ketamine outside a clinical setting can lead to cravings and to symptoms of withdrawal, while noting that more research is needed [1].
This page is about the second situation. It covers when treatment helps, what an assessment weighs, whether withdrawal needs supervision, how the levels of care differ, which therapies have evidence, where medication fits, co-occurring conditions and cost. Our page on ketamine abuse covers the drug itself.
When Ketamine Use Becomes Something Treatment Can Help With
The line is not how often. It is whether stopping has become hard, and whether use keeps going when it is costing something.
Federal research summaries are careful here, and the caution is worth repeating rather than smoothing over. Laboratory research and a few human studies suggest that ketamine used outside a clinical setting can lead to cravings and withdrawal symptoms [1]. The same summaries say more research is needed [1]. Nobody should read that as “not a real problem”. They should read it as a field that is still filling in.
There is also a diagnostic gap. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders includes phencyclidine use disorder and “other hallucinogen use disorder” [1]. It does not carry a separate diagnosis for every dissociative drug [1]. A clinician can still assess and treat what is in front of them. Do not wait for a specific label.
Four patterns bring people to an assessment. Use that has moved from occasional to routine. Doses that have crept up. Time lost to it. And other people noticing first.
Assessment: What a Clinician Looks For Before Recommending a Level of Care
A level of care is the result of an assessment. It is not something a person selects.
The assessment gathers specifics. What is being used, how often, and in what setting. What else is being taken, which matters because illicit supply is frequently not what it is sold as. What earlier attempts to stop looked like. What physical symptoms have appeared, especially urinary and abdominal ones, which people often do not connect to the drug. Federal research summaries say long-term ketamine use may cause ketamine-induced uropathy, a treatable but potentially serious condition that causes symptoms similar to those of a urinary tract infection, and they list abdominal pain among the short-term side effects of this drug class [1]. And what the mental health picture looks like.
Federal research guidance asks for a plan tailored to the person. It should address their own drug use patterns and their drug-related medical, mental and social problems [2]. That is the reason two people with similar use can leave with different recommendations.
Our rehab process page explains where the assessment sits in the sequence. Our levels of care guide describes what it is choosing between.
Does Ketamine Need Medical Detox First?
Sometimes. The honest answer is that it depends on what else is in the picture, and on how the person is doing.
Federal research summaries describe withdrawal symptoms and cravings after non-clinical ketamine use [1]. They also note that the physical side effects of this class of drug, such as headache, nausea or changes in heart rate, are generally not life-threatening [1]. The same summaries attach a caveat to that sentence, and it belongs here: illicitly manufactured or processed drugs may be contaminated with colorless and odorless fentanyl or other dangerous substances that can cause serious adverse events, including overdose and death [1]. That is a meaningful contrast with alcohol and sedatives, where withdrawal itself can kill.
The practical rule follows from that. Where ketamine is the only substance, a supervised setting is usually about monitoring and support rather than medical rescue. Where alcohol, benzodiazepines or opioids are also being used, withdrawal management becomes a medical procedure and the setting changes.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental health crisis, call or text 988.
Federal guidance sets out where withdrawal management happens. It runs from a physician’s office through freestanding programs and partial hospitalization to acute care inpatient units [3]. It maps those onto the five adult detox levels used by the American Society of Addiction Medicine, each with its own staffing pattern [3].
Whatever the setting, treat detox as the opening step. Federal guidance says in terms that detoxification is not substance abuse treatment and rehabilitation [4]. Our medical detox page covers the level of care, and our page on withdrawal symptoms compares drug classes.
Where ketamine treatment can start in Florida
The Recovery Village Umatilla is our campus in Umatilla, Florida, in Lake County northwest of Orlando. It runs medical detox, residential and inpatient care, inpatient rehab for mental health, a partial hospitalization program, outpatient care and aftercare planning. Admissions can check benefits for each level before anything is agreed.
See treatment options in Florida
Verify your insurance
The Recovery Village Umatilla is part of our family of treatment centers. See the Recovery Village Umatilla campus.
Residential Treatment for Ketamine Use, and Who It Suits
Residential care means living at the program. Treatment is the day’s work rather than something fitted around it.
Three situations point toward it. The first is access. Where supply is tied to a place, a group or a routine, removing the environment removes most of the trigger at once. The second is physical health. Federal research summaries say long-term use may cause ketamine-induced uropathy, and they list abdominal pain among this class’s short-term side effects [1]. Where those symptoms have appeared, being somewhere with daily medical contact is worth more than a weekly appointment. The third is mental health, especially where dissociation or low mood has persisted between episodes of use.
One thing does not decide it. Federal summaries describe the physical side effects of this drug class as generally not life-threatening [1], so withdrawal severity is rarely the deciding factor for this drug. That is about withdrawal, not about what is in the supply, where the adulteration caveat above stands on its own. Our inpatient rehab page describes what living at a program involves.
PHP and IOP for Ketamine Use
These two levels carry most ketamine treatment, and the difference between them is hours.
A partial hospitalization program fills most of a clinical day. The person sleeps elsewhere. An intensive outpatient program is lighter. It usually runs as blocks of a few hours, several days a week, around work or study.
For this drug, outpatient care has a specific advantage. Use is often tied to particular settings and particular people. Working on that while still living in it means the plan gets tested in real conditions rather than in theory.
The same fact is the argument against it. If nothing about the setting changes, the program is competing with it every weekend. Our outpatient rehab page sets out how those schedules are built.
Therapies With the Strongest Evidence for This Substance
No medication treats ketamine use, so the therapy is the treatment rather than an addition to it.
Federal research guidance describes cognitive behavioral therapy as work that “seeks to help patients recognize, avoid, and cope with the situations in which they’re most likely to use drugs” [2]. For a drug whose use is usually tied to specific rooms, nights and people, that description is close to a job spec.
The other approach with a strong record is contingency management, which rewards verified abstinence and attendance directly [2]. It sounds too simple to matter. It is one of the few things that shifts behavior quickly, and quickly is what the first month needs.
One more point, and it rests on two sources rather than one. Behavioral therapies can also help people remain in treatment longer [2], and longer time in treatment is itself linked to better outcomes [7].
Ask a program which of these it actually runs, and how often. A weekly group and a structured course of CBT are different things, and both get called therapy.
Our pages on substance abuse counseling techniques and on what CBT is describe those sessions from the inside.
Medication Options, Where They Exist
Two different questions get tangled here, and untangling them is most of the answer.
Question one is whether a drug can be prescribed to treat someone’s ketamine use. Nothing is approved for that. Federal research guidance sets out which classes have a medication behind them, and this is not one of them; where a class has none, it says treatment consists of behavioral therapies [2].
Question two is whether ketamine is itself a medicine. It is, under supervision, and it is being studied further. That has no bearing on question one. People read the second as an answer to the first and it is not. A prescriber makes that call.
What medication does do in a plan is treat what sits alongside. Depression, anxiety and sleep problems are handled on their own terms. Where opioids or alcohol are in the picture too, medication-assisted treatment may apply to those. No amounts or schedules appear here.
Co-occurring Mental Health Conditions and Why They Change the Plan
This is usually what decides the level of care, and it is the part people leave out of the first call.
Federal research summaries note that people using drugs in this class report strong emotions, which can range from intense happiness and connectedness to fear, anxiety and confusion [1]. Where those states persist between episodes of use, that is a clinical question rather than an after-effect to wait out.
Federal research guidance asks that the plan address mental and social problems alongside the drug use [2]. In practice that means two things. Say what the mood has been like on the assessment call, including the parts that are hard to say. And expect the recommendation to move toward daily clinical contact if the answer is significant.
Our page on co-occurring conditions explains how both are treated together. Our guide to how long rehab takes explains why that combination usually lengthens a plan.
Paying for Ketamine Treatment and Verifying Benefits
Your policy decides this, not the drug. A verification of benefits is how you find out what yours says.
Start with the numbers, because people ask about the law second. Our own what rehab costs page publishes a range of $3,000 to $10,000 for a 30-day intensive outpatient program, and $350 to $450 a day for partial hospitalization. Those are this site’s own ranges. They are not federal figures and they are not a quote.
Now the law, because it changes what a plan may do with those numbers. Federal parity rules say a plan covering this care cannot hold it to requirements or limits more restrictive than the predominant ones applied to substantially all medical and surgical benefits in the same class [5]. Who is protected is worth checking. The rules reach non-federal governmental plans with more than 50 employees and private employer group plans with more than 50 employees, plus individual-market coverage [5]. Small-employer group plans fall outside them. Non-grandfathered small-group and individual plans still have to cover this care as an essential health benefit under the Affordable Care Act [5], and Marketplace plans carry no annual or lifetime dollar limits on it [6].
Our insurance coverage guide lists the questions for the call. How to get into rehab covers what happens after it, and our nationwide directory of rehab facilities shows the campuses we run.
Frequently Asked Questions
Do I need inpatient treatment for ketamine use? Not always, and the assessment decides. Federal summaries describe the physical side effects of this drug class as generally not life-threatening, so withdrawal severity is rarely the deciding factor; the same summaries caution that illicitly manufactured or processed drugs may be contaminated with colorless and odorless fentanyl or other dangerous substances. What does decide it is access to supply, physical symptoms such as the ketamine-induced uropathy those summaries describe, and whether a mental health condition needs daily clinical contact.
Is there a medication for ketamine addiction? Nothing is approved to treat it. Federal research guidance sets out which drug classes have a medication behind them, and this is not one. Watch for a common mix-up: ketamine is itself used as a medicine under supervision, which is a separate question entirely. Depression, anxiety or sleep problems alongside the use can still be prescribed for.
How long does ketamine treatment take? Plan for months rather than weeks. Federal research guidance puts the figure at a minimum of three months in treatment for most people, with better results the longer it runs. Read that as total time in care, counted across every level. It is not a number of nights in a bed, and stepping down is not stopping.
Will insurance cover it? Usually some of it, and your own policy decides how much. Parity rules stop a plan that covers this care from holding it to limits stricter than the predominant ones on substantially all medical and surgical benefits. Plans bought on the Marketplace carry no annual or lifetime dollar cap on it. Only a benefits check produces real numbers.
What happens on the first call? Questions, and nothing you have to agree to. The call is confidential. It covers the substance and the pattern, anything else being taken, what has been tried before, current prescriptions, other diagnoses, and who is at home. Benefits usually get checked while you are still on the line. The clinical assessment comes next and sets the level of care.
Sources
- National Institute on Drug Abuse. Psychedelic and Dissociative Drugs. National Institutes of Health. https://nida.nih.gov/research-topics/psychedelic-dissociative-drugs
- National Institute on Drug Abuse. Drugs, Brains, and Behavior: The Science of Addiction — Treatment and Recovery. National Institutes of Health. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 2: Settings, Levels of Care, and Patient Placement. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64109/
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 1: Overview, Essential Concepts, and Definitions in Detoxification. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64119/
- Centers for Medicare and Medicaid Services. The Mental Health Parity and Addiction Equity Act (MHPAEA). https://www.cms.gov/marketplace/private-health-insurance/mental-health-parity-addiction-equity
- HealthCare.gov. Mental Health and Substance Abuse Health Coverage Options. Centers for Medicare and Medicaid Services. https://www.healthcare.gov/coverage/mental-health-substance-abuse-coverage/
- National Institute on Drug Abuse. (2012). Principles of Drug Addiction Treatment: A Research-Based Guide, 3rd edition. National Institutes of Health. https://nida.nih.gov/sites/default/files/podat-3rdEd-508.pdf
This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Author
Chief Medical Officer,
The Recovery Village
